"Valeo Pharma is about creating partnerships, both with International partners and with members of the Canadian Healthcare Industry, to bring innovative products of the highest quality to the market, quickly and efficiently."
A Canadian company based in Kirkland, Quebec, Valeo Pharma is a fully integrated, public traded ("CSE:VPH") specialty pharmaceutical company founded in 2003. Valeo Pharma is devoted to providing healthcare professionals and patients with the highest quality specialty products and healthcare solutions.
Initially created as a company specializing in dermatology, over time Valeo Pharma grew into a more diverse company and competed in a variety of specialty markets. Through acquisitions, in-licensing and selective product development, Valeo Pharma brought over 20 products to the market since inception.
In 2014, Valeo Pharma made the strategic decision to divest of its dermatology portfolio to focus on the commercialization of innovative specialty products addressing the needs of patients in select therapeutic classes.
Driven by our experienced management team with in-depth knowledge of the Canadian market conditions and long-standing relationships with key industry leaders and healthcare professionals, our solid business model provides the required resources to successfully introduce specialty products to Canada.
Valeo Pharma is driven by the desire to become a leading Canadian focussed Specialty Pharmaceutical company and be the partner of choice for International companies wishing to enter the Canadian market. Valeo Pharma continues to identify and capitalize on opportunities to further develop its product line and provide healthcare professionals and patients with therapeutic solutions to meet their needs.